These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23091734)

  • 21. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
    Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y
    J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of the MELD score for the assessment of pre- and post-liver transplantation survival.
    Adler M; De Gendt E; Vereerstraeten P; Degré D; Bourgeois N; Boon N; Gelin M; Ickx B; Donckier V
    Transplant Proc; 2005; 37(6):2863-4. PubMed ID: 16182835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Model for end-stage liver disease. New basis of allocation for liver transplantations].
    Jung GE; Encke J; Schmidt J; Rahmel A
    Chirurg; 2008 Feb; 79(2):157-63. PubMed ID: 18214398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Model for end-stage liver disease (MELD) and allocation of donor livers.
    Wiesner R; Edwards E; Freeman R; Harper A; Kim R; Kamath P; Kremers W; Lake J; Howard T; Merion RM; Wolfe RA; Krom R;
    Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Higher Mortality in registrants with sudden model for end-stage liver disease increase: Disadvantaged by the current allocation policy.
    Massie AB; Luo X; Alejo JL; Poon AK; Cameron AM; Segev DL
    Liver Transpl; 2015 May; 21(5):683-9. PubMed ID: 25762287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans.
    Ahmad J; Downey KK; Akoad M; Cacciarelli TV
    Liver Transpl; 2007 Nov; 13(11):1564-9. PubMed ID: 17969210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of the MELD allocation after its implementation in liver transplantation.
    Benckert C; Quante M; Thelen A; Bartels M; Laudi S; Berg T; Kaisers U; Jonas S
    Scand J Gastroenterol; 2011 Jul; 46(7-8):941-8. PubMed ID: 21443420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
    BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of the MELD score and the UNOS adult liver allocation system.
    Martin AP; Bartels M; Hauss J; Fangmann J
    Transplant Proc; 2007 Dec; 39(10):3169-74. PubMed ID: 18089345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From Child-Pugh to MELD score and beyond: Taking a walk down memory lane.
    Ruf A; Dirchwolf M; Freeman RB
    Ann Hepatol; 2022; 27(1):100535. PubMed ID: 34560316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
    Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differences in access to liver transplantation: disease severity, waiting time, and transplantation center volume.
    Ahmad J; Bryce CL; Cacciarelli T; Roberts MS
    Ann Intern Med; 2007 May; 146(10):707-13. PubMed ID: 17502631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system.
    Piscaglia F; Camaggi V; Ravaioli M; Grazi GL; Zanello M; Leoni S; Ballardini G; Cavrini G; Pinna AD; Bolondi L
    Liver Transpl; 2007 Jun; 13(6):857-66. PubMed ID: 17539006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C; Belghiti J; Castaing D; Chazouillères O; Duclos-Vallée JC; Duvoux C; Lerut J; Le Treut YP; Moreau R; Mandot A; Pageaux G; Samuel D; Thabut D; Valla D; Durand F
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excess mortality on the liver transplant waiting list: unintended policy consequences and Model for End-Stage Liver Disease (MELD) inflation.
    Northup PG; Intagliata NM; Shah NL; Pelletier SJ; Berg CL; Argo CK
    Hepatology; 2015 Jan; 61(1):285-91. PubMed ID: 24995689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is waiting time a measure of access to liver transplantation? Is shorter necessarily better?
    Freeman RB
    Hepatology; 2007 Aug; 46(2):602-3. PubMed ID: 17661416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation.
    Samuel D; Coilly A
    BMC Med; 2018 Aug; 16(1):113. PubMed ID: 30064414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.